Allianz Asset Management
WVE icon

Allianz Asset Management’s Wave Life Sciences WVE Stock Holding History

Allianz Asset Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,000
Closed -$374K – 2119
2025
Q4 		$374K Buy
+22,000
New +$224K ﹤0.01% 1872
2020
Q1 		– Sell
-17,267
Closed -$139K – 2767
2019
Q4 		$139K Sell
17,267
-4,865
-22% -$119K ﹤0.01% 2706
2019
Q3 		$454K Sell
22,132
-19,370
-47% -$444K ﹤0.01% 2395
2019
Q2 		$1.08M Sell
41,502
-63,354
-60% -$1.78M ﹤0.01% 2112
2019
Q1 		$4.07M Buy
104,856
+2,117
+2% +$85.9K ﹤0.01% 1551
2018
Q4 		$4.33M Sell
102,739
-20,811
-17% -$925K ﹤0.01% 1472
2018
Q3 		$6.18M Sell
123,550
-10,313
-8% -$465K 0.01% 1471
2018
Q2 		$5.12M Buy
+133,863
New +$5.76M 0.01% 1510

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Allianz Asset Management's WVE Position: Q1 2026 in Review

Allianz Asset Management sold out of Wave Life Sciences (WVE) in Q1 2026, closing a stake of 22,000 shares — an estimated $374K sold.

Allianz Asset Management first reported a position in WVE in Q2 2018 and held it in 8 quarters. The position peaked at $6.18M in Q3 2018. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Allianz Asset Management reported no remaining Wave Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Allianz Asset Management sold 22,000 Wave Life Sciences shares in Q1 2026, an estimated $374K.
  • Allianz Asset Management first reported a position in Wave Life Sciences in Q2 2018 and held it in 8 quarters.
  • Allianz Asset Management's Wave Life Sciences position peaked at $6.18M in Q3 2018.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.